Skip to main navigation Skip to search Skip to main content

Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies

  • Elisabet E. Manasanch
  • , David Berrios
  • , Eric Fountain
  • , Catherine M. Claussen
  • , Tammy Chuang
  • , Gregory Kaufman
  • , Behrang Amini
  • , Qaiser Bashir
  • , Yago Nieto
  • , Muzaffar Qazilbash
  • , Krina Patel
  • , Sheeba K. Thomas
  • , Donna M. Weber
  • , Zuzana Berkova
  • , Gokce Toruner
  • , Pei Lin
  • , Lei Feng
  • , Hans C. Lee
  • , Robert Z. Orlowski
  • , Chutima Kunacheewa
  • The University of Texas MD Anderson Cancer Center

Research output: Contribution to journalLetterpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)e115-e120
JournalBritish Journal of Haematology
Volume192
Issue number4
DOIs
Publication statusPublished - Feb 2021
Externally publishedYes

Keywords

  • HR myeloma
  • gene expression profiling
  • multiple myeloma
  • novel therapy

Cite this